Private Trust Company’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-110
Closed -$3.33K 2333
2023
Q2
$3.33K Sell
110
-88
-44% -$2.85K ﹤0.01% 1993
2023
Q1
$6.42K Sell
198
-65
-25% -$2.06K ﹤0.01% 1764
2022
Q4
$7K Buy
263
+62
+31% +$1.78K ﹤0.01% 1672
2022
Q3
$7K Hold
201
﹤0.01% 1565
2022
Q2
$6K Buy
+201
New +$5.86K ﹤0.01% 1681

Other funds holding EVH

Private Trust Company's EVH Position: Q3 2023 in Review

Private Trust Company sold out of Evolent Health (EVH) in Q3 2023, closing a stake of 110 shares — an estimated $3.33K sold.

Private Trust Company first reported a position in EVH in Q2 2022 and held it in 5 quarters. The position peaked at $7K in Q4 2022. 203 funds tracked by Wall St. Rank hold EVH as of Q3 2023.

  • Private Trust Company reported no remaining Evolent Health position as of Q3 2023 after selling out during the quarter.
  • Private Trust Company sold 110 Evolent Health shares in Q3 2023, an estimated $3.33K.
  • Private Trust Company first reported a position in Evolent Health in Q2 2022 and held it in 5 quarters.
  • Private Trust Company's Evolent Health position peaked at $7K in Q4 2022.
  • 203 funds tracked by Wall St. Rank held Evolent Health as of Q3 2023.

Based on Private Trust Company's 13F filing for Q3 2023, filed 18 Oct 2023.